Literature DB >> 82891

Alpha-glucoside hydrolase inhibition in diabetes.

H Vierhapper, A Bratusch-Marrain, W Waldhäusl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 82891     DOI: 10.1016/s0140-6736(78)92030-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Acute and short term effects of intestinal alpha-glucosidase inhibition on gut hormone responses in man.

Authors:  L O Uttenthal; O O Ukponmwan; M Ghiglione; S R Bloom
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

2.  Effect of a long-term acarbose therapy on the metabolic control of sulphonylurea-treated diabetic patients.

Authors:  G Sachse; H Laube; E Mäser; K Federlin
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

Review 3.  Oral antidiabetic drug use in the elderly.

Authors:  R Bressler; D G Johnson
Journal:  Drugs Aging       Date:  1996-12       Impact factor: 3.923

4.  Delaying carbohydrate absorption in noninsulin-dependent diabetes mellitus: useful therapy?

Authors:  H S Füessl
Journal:  Klin Wochenschr       Date:  1987-05-04

5.  Long-term treatment of sulphonylurea-treated diabetics with the alpha-glucosidase inhibitor Bay g 5421 (acarbose)

Authors:  H Vierhapper; P Bratusch-Marrain; W Waldhäusl
Journal:  Diabetologia       Date:  1981-05       Impact factor: 10.122

6.  Reduction of postprandial blood glucose by the alpha-glucosidase inhibitor Miglitol (BAY m 1099) in type II diabetes.

Authors:  G Heinz; M Komjati; A Korn; W Waldhäusl
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.